138 related articles for article (PubMed ID: 16828710)
1. Small heat shock proteins differentially affect Abeta aggregation and toxicity.
Lee S; Carson K; Rice-Ficht A; Good T
Biochem Biophys Res Commun; 2006 Aug; 347(2):527-33. PubMed ID: 16828710
[TBL] [Abstract][Full Text] [Related]
2. Small heat shock proteins inhibit amyloid-beta protein aggregation and cerebrovascular amyloid-beta protein toxicity.
Wilhelmus MM; Boelens WC; Otte-Höller I; Kamps B; de Waal RM; Verbeek MM
Brain Res; 2006 May; 1089(1):67-78. PubMed ID: 16635482
[TBL] [Abstract][Full Text] [Related]
3. Hsp20, a novel alpha-crystallin, prevents Abeta fibril formation and toxicity.
Lee S; Carson K; Rice-Ficht A; Good T
Protein Sci; 2005 Mar; 14(3):593-601. PubMed ID: 15722443
[TBL] [Abstract][Full Text] [Related]
4. The molecular chaperone alphaB-crystallin enhances amyloid beta neurotoxicity.
Stege GJ; Renkawek K; Overkamp PS; Verschuure P; van Rijk AF; Reijnen-Aalbers A; Boelens WC; Bosman GJ; de Jong WW
Biochem Biophys Res Commun; 1999 Aug; 262(1):152-6. PubMed ID: 10448084
[TBL] [Abstract][Full Text] [Related]
5. The recombinant amyloid-beta peptide Abeta1-42 aggregates faster and is more neurotoxic than synthetic Abeta1-42.
Finder VH; Vodopivec I; Nitsch RM; Glockshuber R
J Mol Biol; 2010 Feb; 396(1):9-18. PubMed ID: 20026079
[TBL] [Abstract][Full Text] [Related]
6. Peptide and protein mimetics inhibiting amyloid beta-peptide aggregation.
Takahashi T; Mihara H
Acc Chem Res; 2008 Oct; 41(10):1309-18. PubMed ID: 18937396
[TBL] [Abstract][Full Text] [Related]
7. Formation of highly toxic soluble amyloid beta oligomers by the molecular chaperone prefoldin.
Sakono M; Zako T; Ueda H; Yohda M; Maeda M
FEBS J; 2008 Dec; 275(23):5982-93. PubMed ID: 19021772
[TBL] [Abstract][Full Text] [Related]
8. Design and biological activity of beta-sheet breaker peptide conjugates.
Rocha S; Cardoso I; Börner H; Pereira MC; Saraiva MJ; Coelho M
Biochem Biophys Res Commun; 2009 Mar; 380(2):397-401. PubMed ID: 19250644
[TBL] [Abstract][Full Text] [Related]
9. Metal ions differentially influence the aggregation and deposition of Alzheimer's beta-amyloid on a solid template.
Ha C; Ryu J; Park CB
Biochemistry; 2007 May; 46(20):6118-25. PubMed ID: 17455909
[TBL] [Abstract][Full Text] [Related]
10. Development of a novel diffusion-based method to estimate the size of the aggregated Abeta species responsible for neurotoxicity.
Wang SS; Becerra-Arteaga A; Good TA
Biotechnol Bioeng; 2002 Oct; 80(1):50-9. PubMed ID: 12209786
[TBL] [Abstract][Full Text] [Related]
11. Engineered antibody intervention strategies for Alzheimer's disease and related dementias by targeting amyloid and toxic oligomers.
Robert R; Dolezal O; Waddington L; Hattarki MK; Cappai R; Masters CL; Hudson PJ; Wark KL
Protein Eng Des Sel; 2009 Mar; 22(3):199-208. PubMed ID: 18927231
[TBL] [Abstract][Full Text] [Related]
12. Surface structure of amyloid-beta fibrils contributes to cytotoxicity.
Yoshiike Y; Akagi T; Takashima A
Biochemistry; 2007 Aug; 46(34):9805-12. PubMed ID: 17676931
[TBL] [Abstract][Full Text] [Related]
13. Beta-amyloid fibril formation is promoted by step edges of highly oriented pyrolytic graphite.
Losic D; Martin LL; Aguilar MI; Small DH
Biopolymers; 2006; 84(5):519-26. PubMed ID: 16752395
[TBL] [Abstract][Full Text] [Related]
14. Abeta(25-35) and its C- and/or N-blocked derivatives: copper driven structural features and neurotoxicity.
Giuffrida ML; Grasso G; Ruvo M; Pedone C; Saporito A; Marasco D; Pignataro B; Cascio C; Copani A; Rizzarelli E
J Neurosci Res; 2007 Feb; 85(3):623-33. PubMed ID: 17131391
[TBL] [Abstract][Full Text] [Related]
15. alphaB-crystallin competes with Alzheimer's disease beta-amyloid peptide for peptide-peptide interactions and induces oxidation of Abeta-Met35.
Narayanan S; Kamps B; Boelens WC; Reif B
FEBS Lett; 2006 Oct; 580(25):5941-6. PubMed ID: 17046756
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of beta-amyloid peptide aggregation and neurotoxicity by alpha-d-mannosylglycerate, a natural extremolyte.
Ryu J; Kanapathipillai M; Lentzen G; Park CB
Peptides; 2008 Apr; 29(4):578-84. PubMed ID: 18304694
[TBL] [Abstract][Full Text] [Related]
17. Amyloid-beta aggregates formed at polar-nonpolar interfaces differ from amyloid-beta protofibrils produced in aqueous buffers.
Nichols MR; Moss MA; Reed DK; Hoh JH; Rosenberry TL
Microsc Res Tech; 2005 Jul; 67(3-4):164-74. PubMed ID: 16103999
[TBL] [Abstract][Full Text] [Related]
18. Specific interaction of VEGF165 with beta-amyloid, and its protective effect on beta-amyloid-induced neurotoxicity.
Yang SP; Kwon BO; Gho YS; Chae CB
J Neurochem; 2005 Apr; 93(1):118-27. PubMed ID: 15773911
[TBL] [Abstract][Full Text] [Related]
19. Designing peptide inhibitors for oligomerization and toxicity of Alzheimer's beta-amyloid peptide.
Austen BM; Paleologou KE; Ali SA; Qureshi MM; Allsop D; El-Agnaf OM
Biochemistry; 2008 Feb; 47(7):1984-92. PubMed ID: 18189413
[TBL] [Abstract][Full Text] [Related]
20. Both the D-(+) and L-(-) enantiomers of nicotine inhibit Abeta aggregation and cytotoxicity.
Moore SA; Huckerby TN; Gibson GL; Fullwood NJ; Turnbull S; Tabner BJ; El-Agnaf OM; Allsop D
Biochemistry; 2004 Jan; 43(3):819-26. PubMed ID: 14730987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
